TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy
Aim: We evaluated a novel approach combining the use of attenuated Salmonella immunotherapy with a Toll-like receptor agonist, imiquimod, in B16F1 melanoma-bearing mice. Materials & methods: B16F1 melanoma-bearing mice were daily treated with topical imiquimod in combination with one intratumoral in...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , |
| Format: | article |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/42097 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy
- Salmonella-Induced Cell Death in Cancer Immunotherapy: What Lies Beneath?
- Infammasome activation, NLRP3 engagement and macrophage recruitment to tumor microenvironment are all required for Salmonella antitumor efect
- Informe final del proyecto: Proteoma de la interacción Salmonella-tumor como herramienta para profundizar en el efecto antimelanoma de Salmonella
- Draft genome sequence of Catenibacterium mistuoki isolated from the fecal sample of a melanoma patient with complete response to immunotherapy
- Experience with immunotherapy in malignant melanoma
- Salmonella LVR01 triggers antagonistic two-armed innate immune memory that impacts on antitumor efficacy